Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alexey Bulychev is active.

Publication


Featured researches published by Alexey Bulychev.


Tetrahedron | 2000

N-Sulfonyloxy-β-lactam Inhibitors for β-Lactamases

Alexey Bulychev; John R. Bellettini; Michael O'Brien; Peter J. Crocker; Jean-Pierre Samama; Marvin J. Miller; Shahriar Mobashery

Abstract Structure-function analysis with a series of N-sulfonyloxy β-lactam molecules as inhibitors of β-lactamases is reported. The best of these compounds acylate the active site of the class A TEM-1 β-lactamase from Escherichia coli rapidly, and resist deacylation. Whereas acylation of the active site of the class C β-lactamase from Enterobacter cloacae was not seen, these compounds function as competitive inhibitors of this enzyme.


Journal of Biological Chemistry | 1999

Inhibition of the broad spectrum nonmetallocarbapenamase of class A (NMC-A) beta-lactamase from Enterobacter cloacae by monocyclic beta-lactams.

Mourey L; Lakshmi P. Kotra; Bellettini J; Alexey Bulychev; O'Brien M; Miller Mj; Shahriar Mobashery; Samama Jp

β-Lactamases hydrolyze β-lactam antibiotics, a reaction that destroys their antibacterial activity. These enzymes, of which four classes are known, are the primary cause of resistance to β-lactam antibiotics. The class A β-lactamases form the largest group. A novel class A β-lactamase, named the nonmetallocarbapenamase of class A (NMC-A) β-lactamase, has been discovered recently that has a broad substrate profile that included carbapenem antibiotics. This is a serious development, since carbapenems have been relatively immune to the action of these resistance enzymes. Inhibitors for this enzyme are sought. We describe herein that a type of monobactam molecule of our design inactivates the NMC-A β-lactamase rapidly, efficiently, and irreversibly. The mechanism of inactivation was investigated by solving the x-ray structure of the inhibited NMC-A enzyme to 1.95 Å resolution. The structure shed light on the nature of the fragmentation of the inhibitor on enzyme acylation and indicated that there are two acyl-enzyme species that account for enzyme inhibition. Each of these inhibited enzyme species is trapped in a distinct local energy minimum that does not predispose the inhibitor species for deacylation, accounting for the irreversible mode of enzyme inhibition. Molecular dynamics simulations provided evidence in favor of a dynamic motion for the acyl-enzyme species, which samples a considerable conformational space prior to the entrapment of the two stable acyl-enzyme species in the local energy minima. A discussion of the likelihood of such dynamic motion for turnover of substrates during the normal catalytic processes of the enzyme is presented.


Bioorganic & Medicinal Chemistry Letters | 1998

Templates for design of inhibitors for serine proteases: Application of the program dock to the discovery of novel inhibitors for thrombin

Irina Massova; Philip D. Martin; Alexey Bulychev; Remek Kocz; M. A. Doyle; Brian F.P. Edwards; Shahriar Mobashery

The program DOCK was used to search for novel inhibitors for alpha-thrombin. Four among the top twelve best scoring compounds from the Cambridge Structural Data Base inhibited this enzyme, and three of them inhibited alpha-thrombin in a competitive mode. These molecules are expected to serve as general templates for structural elaboration in targeting diverse serine proteases for selective inhibition.


Journal of the American Chemical Society | 1998

Inhibition of the NMC-A β-lactamase by a penicillanic acid derivative, and the structural bases for the increase in substrate profile of this antibiotic resistance enzyme

Lionel Mourey; Kazuyuki Miyashita; Peter Swaren; Alexey Bulychev; Jean-Pierre Samama; Shahriar Mobashery


Biochemistry | 1999

X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.

Peter Swaren; Dasantila Golemi; Stéphanie Cabantous; Alexey Bulychev; Laurent Maveyraud; Shahriar Mobashery; Jean-Pierre Samama


Journal of the American Chemical Society | 1997

Nuances of Mechanisms and Their Implications for Evolution of the Versatile β-Lactamase Activity: From Biosynthetic Enzymes to Drug Resistance Factors

Alexey Bulychev; Irina Massova; Kazuyuki Miyashita; Shahriar Mobashery


Antimicrobial Agents and Chemotherapy | 1999

Class C β-Lactamases Operate at the Diffusion Limit for Turnover of Their Preferred Cephalosporin Substrates

Alexey Bulychev; Shahriar Mobashery


Journal of the American Chemical Society | 1995

PENEM BRL 42715 : AN EFFECTIVE INACTIVATOR FOR BETA -LACTAMASES

Alexey Bulychev; Irina Massova; Stephen A. Lerner; Shahriar Mobashery


Journal of the American Chemical Society | 1995

Potent mechanism-based inhibition of the TEM-1 .beta.-lactamase by novel N-sulfonyloxy .beta.-lactams

Alexey Bulychev; Michael O'Brien; Irina Massova; Min Teng; Tracy A. Gibson; Marvin J. Miller; Shahriar Mobashery


Journal of the American Chemical Society | 1999

Elucidation of Mechanism of Inhibition and X-ray Structure of the TEM-1 β-Lactamase from Escherichia coli Inhibited by a N-Sulfonyloxy-β-lactam

Peter Swaren; Irina Massova; John R. Bellettini; Alexey Bulychev; Laurent Maveyraud; Lakshmi P. Kotra; Marvin J. Miller; Shahriar Mobashery; Jean-Pierre Samama

Collaboration


Dive into the Alexey Bulychev's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Irina Massova

University of California

View shared research outputs
Top Co-Authors

Avatar

Jean-Pierre Samama

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter Swaren

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laurent Maveyraud

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge